Cantor Fitzgerald Maintains a Hold on Pfizer (PFE)

Group 1 - Pfizer Inc. is recognized as one of the best medical stocks to buy currently, with a Hold rating maintained by Carter Gould from Cantor Fitzgerald and a price target set at $24.00 [1] - On September 30, Pfizer announced a historic agreement with the Trump Administration aimed at reducing prescription medicine prices for US patients while enhancing the US's position in biopharmaceutical innovation [2] - In response to a letter from the President dated July 31, Pfizer has voluntarily agreed to implement measures ensuring that Americans receive drug prices comparable to those in other developed countries and to price newly launched medicines at parity with other key developed markets [3] Group 2 - Pfizer Inc. operates as a global biopharmaceutical company, focusing on the manufacturing, development, marketing, and sale of biopharmaceutical products worldwide, with an emphasis on wellness, prevention, treatment, and cures in developing and emerging markets [4]